Alitretinoin topical gel (Panretin gel; Ligand Pharmaceuticals Inc, San Diego, Calif) is effective and well tolerated for the treatment of cutaneous lesions in patients with acquired immunodeficiency syndrome–related Kaposi sarcoma (KS),1- 4 offering patients a self-administered, noninvasive, topical alternative treatment. To my knowledge, effective treatment of classic KS with this formulation has not been described.
Morganroth GS. Topical 0.1% Alitretinoin Gel for Classic Kaposi Sarcoma. Arch Dermatol. 2002;138(4):542-543. doi:10.1001/archderm.138.4.533